""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_component_original"	"response_component"	"cell_ontology_id"	"proterm_and_extra"	"pro_ontology_id"	"fully_qualified_response_component"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"baseline_time"	"target_pathogen"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"cohort"	"publication_reference"	"publication_year"	"signature_source"	"signature_source_url"	"comments"	"publication_reference_url"	"age_group"	"age_min"	"age_max"	"age_units"	"subm_obs_id"	"uniq_obs_id"	"response_comp_cnt"	"signature_file"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	""	""	""	""	"pathogen"	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"file"
"role"	""	""	""	"tissue"	"observed"	"cell_biomarker"	"observed"	"observed"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"pathogen"	"background"	"background"	"vaccine"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"background"	"reference"	"observed"	"observed"	"observed"	"observed"	"background"	"background"	"observed"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response component (original)"	"response component (cell subset)"	"cell ontology ID"	"cell type PRO and extra terms"	"protein ontology ID"	"all response components in signature"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"baseline time"	"target pathogen"	"vaccine year"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"comparison"	"cohort"	"publication reference (PMID)"	"publication year"	"signature source figure, table or text section"	"signature source url"	"comments and additional details"	"Rechtien et al. (2017) Systems Vaccinology Identifies an Early Innate Immune Signature as a Correlate of Antibody Responses to the Ebola Vaccine rVSV-ZEBOV. Cell Rep PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=28854372' target='_blank'>28854372</a>"	"cohort"	"min. age"	"max. age"	"age units"	"ID of observation within its submission"	"Uniq ID of observation within submission type"	"response component count"	"signature response component (cell types) file"
""	"hipc_ctf_28854372_1"	"2017.08"	"hipc_ctf_28854372_1"	"peripheral blood mononuclear cell"	"CD56-bright natural killer (NK) cells"	"natural killer cell"	"CL_0000623"	"& CD56-bright"	"PR:000001024"	"natural killer cell & CD56-bright"	"cell type frequency"	"positively"	"none"	"3"	"Days"	"time of vaccination (first dose)"	"ebola virus"	""	"rVSV-EBOV"	"VO_0004660"	""	"positively correlated with antibody response at 28d and onward. "	"adults (18-55)"	"28854372"	"2017"	"Fig 4"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=28854372"	"adults"	"18"	"55"	"years"	"1"	"17"	"1"	"hipc_ctf_sig_28854372_1.txt"
